key: cord-0892050-a9tc7v2q authors: Borucki, Robert; Concha, Josef Symon S.; Burroughs, Julie; Okawa, Joyce; Werth, Victoria P. title: Managing interventional clinical trials in the setting of COVID-19: Experience in an autoimmune skin disease unit date: 2020-12-22 journal: JAAD international DOI: 10.1016/j.jdin.2020.11.002 sha: 2a9f6e0d1ffad041a578a17b10aad5d9265270f2 doc_id: 892050 cord_uid: a9tc7v2q nan Other specialties, such as oncology, also continued in-person visits for essential study 71 procedures, though opted for telemedicine when possible. 1 Although the use of teledermatology 72 in clinical trials could be favorable during a pandemic, this approach needs further investigation. Adapting to a Pandemic -Conducting Oncology Trials 83 during the SARS-CoV-2 Pandemic Inter-rater reliability 85 of cutaneous sarcoidosis assessment tools via remote photographic assessment Quality of life in 88 cutaneous lupus erythematosus